Moleculeralabs
1 known investors
Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease. The company operates an integrated platform combining diagnostic panels, a biorepository with bioinformatics, and a therapeutic target identification program.
AI & Machine LearningBiotechDigital HealthMedical Devices